Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors
NCT06243185
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Ovarian Carcinoma
Interventions
DRUG:
Dalpiciclib plus letrozole
Sponsor
Fengzhi Feng